ACTR1B and carcinoma: Of note, pnpla6 and Actr1b, the indicators of a favorable outcome in PDAC patients and other carcinomas (https://www.proteinatlas.org/), were also reduced in IFN-γ + INCB24360 and INCB24360 treated KPIC PDAC organoids.